The goal of the Cancer Epidemiology Program is to study environmental, genetic, and molecular risks for cancer and cancer outcomes with an emphasis on disparities. Because we are a public comprehensive cancer center and because North Carolina in many ways mimics the American population, the Program addresses these important questions through multidimensional North Carolina population-based and hospital-based studies. Notable translational cross-program research and high impact publications have been obtained in an inter-disciplinary manner with members of the cancer control and prevention, clinical, genetics, breast, cancer, cell biology and other programs. Program members conduct research with great impact, including population- based studies in breast, colon, prostate, and head and neck cancer, throughout our catchment area (the state of North Carolina) and at UNC Hospital; and the program is focused on cancer health disparities, especially black-white differences. This innovative research model successfully integrates classic risk factor epidemiology, molecular and genetic epidemiology, tumor biology, clinical factors, and prospective follow-up for outcomes. For example, the Program?s Carolina Breast Cancer Study has reshaped our understanding of disparities in breast cancer risk factors, tumor biology, and mortality among African-American women. New and novel North Carolina-based studies in bladder, head and neck, and kidney cancer are planned. Program members collaborate in national and international consortia and with other cancer centers. The Program brings value to the Center through population- and hospital based studies that include systematic collection of exposure, outcome data, and biospecimens, a unique shared resource (Rapid Case Ascertainment), and its expertise in epidemiologic methods development and application. The Program effectively obtains value from the center through UNC Lineberger?s strong support for faculty recruitments, extensive support for important shared resources and developmental funds, which members leverage. The UNC Lineberger strategic plan emphasis on optimizing cancer outcomes in North Carolina led to significant investment across the population sciences including significant faculty recruiting. CE recruited 11 new program members both nationally- recognized senior investigators and promising junior faculty. There are 23 members from 7 different departments in the Schools of Public Health and Medicine and the College of Arts and Sciences. During the last funding period, program members have published 629 cancer- related articles (38% collaborative). In 2014, our program members held 53 grants and $13M (total cost) in annual extramural funding, including 25 grants and $6.6M (total costs) from the NCI.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834880
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lim, Joseph K; Liapakis, Ann Marie; Shiffman, Mitchell L et al. (2018) Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol 16:1811-1819.e4
Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D et al. (2018) Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Sci Rep 8:3199
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Lianga, Noel; Doré, Carole; Kennedy, Erin K et al. (2018) Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset. PLoS Genet 14:e1007029
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Cameron, Jennifer E; Rositch, Anne F; Vielot, Nadja A et al. (2018) Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sex Transm Dis 45:666-672
Dronamraju, Raghuvar; Jha, Deepak Kumar; Eser, Umut et al. (2018) Set2 methyltransferase facilitates cell cycle progression by maintaining transcriptional fidelity. Nucleic Acids Res 46:1331-1344
Koehler, Jennifer W; Miller, Andrew D; Miller, C Ryan et al. (2018) A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. J Neuropathol Exp Neurol 77:1039-1054
Takaku, Motoki; Grimm, Sara A; Roberts, John D et al. (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9:1059

Showing the most recent 10 out of 1525 publications